DIO News

DIO, the first LPGA tour in the global medical device industry

USA 25 April, 2022

‘2022 DIO Implant LA Open’ ended successfully
The LPGA Tour "2022 DIO Implant LA Open," held by DIO for four days at the Wilshire Country Club in Los Angeles, USA, ended successfully from April 21 to 24.
DIO participated as the title sponsor for the first time in the global medical device industry at this LPGA competition, drawing attention every day, and added meaning by holding it in LA, USA. DIO has established a bridgehead to expand the global market by establishing the LA office building of the American corporation to advance into the American premium market. It is evaluated that DIO, who has settled down stably by continuously supplying digital solutions to the US market, made this competition a success and raised brand awareness.
In addition, the news of Korean companies' participation in the LPGA title sponsorship encouraged Korean residents in Los Angeles, the largest Korean community in the United States, to feel pride. As a result, countless Koreans participated in the gallery and watched the game in person and cheered enthusiastically.
A large number of world-class players participated in this tournament, and fierce competition until the last day raised the quality of the tournament. In the final round, Nasa Hataoka of Japan took the final victory. Korean players made it to the top of the list and made the tournament shine, and Inbee Park finished the tournament with the best performance of the season in 3rd place, making people look forward to the next tournament.
CEO Jinbaek Kim of DIO said, “Even though it was the first tournament to sponsor the title, a large number of top-ranked players participated in the tournament, and the tournament was successfully completed thanks to the passionate shouts and support of golf fans around the world.” And he said “Next year’s DIO Implant LA Open is also ambitious. We will prepare it cold and make it a tournament that meets the expectations of golf fans around the world.”
Pre2 / 2 Next